Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine

This publication has 50 references indexed in Scilit:

• Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
  Cancer Research, 2005
• Primary Antitumor Immune Response Mediated by CD4+ T Cells
  Immunity, 2005
• Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
  Immunity, 2005
• Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo
  Immunology, 2004
• CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
  European Journal of Immunology, 2004
• Anti‐tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution
  European Journal of Immunology, 2003
• Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration
  Blood, 2003
• CpG Motifs in Bacterial DNA and Their Immune Effects
  Annual Review of Immunology, 2002
• Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
  Nature Immunology, 2001
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
  The Journal of Experimental Medicine, 2001